Journal Article

Multiple-endpoint in vitro carcinogenicity test in human cell line TK6 distinguishes carcinogens from non-carcinogens and highlights mechanisms of action

Doak, Shareen H, Stannard, Leanne M, Tonkin, James A, Shah Ume-Kulsoom, Doherty, Ann T, Rowan, Brown M, Chapman, Katherine E, Chapman, Fiona M, Seager, Anna L, Jenkins, Gareth J, Wilde, Eleanor C, Johnson, George E, Verma, Jatin R

2021

Overview

Current in vitro genotoxicity tests can produce misleading positive results, indicating an inability to effectively predict a compound’s subsequent carcinogenic potential in vivo. Such oversensitivity can incur unnecessary in vivo tests to further investigate positive in vitro results, supporting the need to improve in vitro tests to better inform risk assessment. It is increasingly acknowledged that more informative in vitro tests using multiple endpoints may support the correct identification of carcinogenic potential. The present study, therefore, employed a holistic, multiple-endpoint approach using low doses of selected carcinogens and non-carcinogens (0.001–770 µM) to assess whether these chemicals caused perturbations in molecular and cellular endpoints relating to the Hallmarks of Cancer. Endpoints included micronucleus induction, alterations in gene expression, cell cycle dynamics, cell morphology and bioenergetics in the human lymphoblastoid cell line TK6. Carcinogens ochratoxin A and oestradiol produced greater Integrated Signature of Carcinogenicity scores for the combined endpoints than the “misleading” in vitro positive compounds, quercetin, 2,4-dichlorophenol and quinacrine dihydrochloride and toxic non-carcinogens, caffeine, cycloheximide and phenformin HCl. This study provides compelling evidence that carcinogens can successfully be distinguished from non-carcinogens using a holistic in vitro test system. Avoidance of misleading in vitro outcomes could lead to the reduction and replacement of animals in carcinogenicity testing.

• Publisher: Springer Nature B.V
• Subject: 2,4-Dichlorophenol / Biocompatibility / Bioenergetics / Biomedical materials / Biotechnology / Caffeine / Carcinogenicity / Carcinogenicity testing / Carcinogens / Cell cycle / Cell morphology / Cycloheximide / Cytology / Gene expression / Genotoxicity / In vitro methods and tests / In vivo methods and tests / Morphology / Ochratoxin A / Quercetin / Quinacrine / Risk assessment